4530.T实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 14:15):

Stats
今日成交量	323 000
平均成交量	177 501
市值	283.28B
EPS	¥0 ( 2024-04-10 )
下一个收益日期	( ¥0 ) 2024-07-11
Last Dividend	¥42.50 ( 2023-08-30 )
Next Dividend	¥0 ( N/A )
P/E	20.28
ATR14	¥1.742 (0.05%)

音量相关性

長: -0.13 (neutral)

短: -0.98 (very strong negative)

Signal:(18.324) Possible Trading Opportunity Present (swing)

Hisamitsu Pharmaceutical 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Hisamitsu Pharmaceutical 相关性 - 货币/商品

0.06
( neutral )

0.57
( weak )

-0.83
( strong negative )

-0.13
( neutral )

0.26
( neutral )

Hisamitsu Pharmaceutical 财务报表

Annual	2023
营收:	¥141.71B
毛利润:	¥78.97B (55.73 %)
EPS:	¥181.62

FY	2023
营收:	¥141.71B
毛利润:	¥78.97B (55.73 %)
EPS:	¥181.62

FY	2022
营收:	¥128.33B
毛利润:	¥72.70B (56.65 %)
EPS:	¥148.00

FY	2022
营收:	¥120.19B
毛利润:	¥70.07B (58.30 %)
EPS:	¥118.92

Financial Reports:

No articles found.

Hisamitsu Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0.250 (N/A)	¥0 (N/A)	¥0.250 (N/A)	¥0 (N/A)	¥42.50 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Hisamitsu Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.60 - Stable (8.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥7.00	2001-02-23
Last Dividend	¥42.50	2023-08-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	42	--
Total Paid Out	¥1 175.50	--
Avg. Dividend % Per Year	0.00%	--
Score	3.73	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.60
Div. Directional Score	7.69	--

Next Divdend (Est)
(2024-09-05)

¥0 Estimate 7.25 %

Dividend Stability

0.29 Very Poor

Dividend Score

3.73

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8387.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7806.T	Ex Dividend Junior	2023-09-28	Sporadic	0.00%
6958.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
6310.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
5101.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
4238.T	Ex Dividend Knight	2023-07-28	Semi-Annually	0.00%
3454.T	Ex Dividend Junior	2023-11-29	Annually	0.00%
2594.T	Ex Dividend Knight	2023-09-28	Annually	0.00%
9010.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
8113.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0986	1.500	8.03	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0425	1.200	8.58	10.00	[0 - 0.3]
returnOnEquityTTM	0.0524	1.500	-0.529	-0.793	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.22	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.66	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.45	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00455	-1.500	9.92	-10.00	[0 - 0.6]
interestCoverageTTM	731.56	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	96.01	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	96.01	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.00565	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.557	1.000	4.05	4.05	[0.2 - 0.8]
operatingProfitMarginTTM	0.0929	1.000	-0.142	-0.142	[0.1 - 0.6]
cashFlowToDebtRatioTTM	4.86	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.431	0.800	-0.460	-0.368	[0.5 - 2]
Total Score				10.77

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	20.30	1.000	8.05	0	[1 - 100]
returnOnEquityTTM	0.0524	2.50	-0.340	-0.793	[0.1 - 1.5]
freeCashFlowPerShareTTM	96.01	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	2.27	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	96.01	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.894	1.500	7.38	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0514	1.000	-1.216	0	[0.1 - 0.5]
Total Score				4.60

Hisamitsu Pharmaceutical

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.